P66Shc-rac1 pathway-mediated ROS production and cell migration is downregulated by ascorbic acid

References

• Migliaccio E, Mele S, Salcini AE, et al. Opposite effects of the p52shc/p46shc and p66shc splicing isoforms on the EGF receptor-MAP kinase-fos signalling pathway. EMBO J 1997;16:706–16
   PubMed Web of Science ®Google Scholar
• Ravichandran KS. Signaling via Shc family adapter proteins. Oncogene 2001;20:6322–30
   PubMed Web of Science ®Google Scholar
• Migliaccio E, Giorgio M, Mele S, et al. The p66shc adaptor protein controls oxidative stress response and life span in mammals. Nature 1999;402:309–13
   PubMed Web of Science ®Google Scholar
• Pacini S, Pellegrini M, Migliaccio E, et al. P66shc promotes apoptosis and antagonizes mitogenic signaling in T cells. Mol Cell Biol 2004;24:1747–57
   PubMed Web of Science ®Google Scholar
• Nemoto S, Finkel T. Redox regulation of forkhead proteins through a p66shc dependent signaling pathway. Science 2002;291:2450–2
   Google Scholar
• Giorgio M, Migliaccio E, Orsini F, et al. Electron transfer between cytochrome c and p66Shc generates reactive oxygen species that trigger mitochondrial apoptosis. Cell 2005;122:221–33
   PubMed Web of Science ®Google Scholar
• Khanday FA, Yamamori T, Singh IM, et al. Rac1 leads to phosphorylation-dependent increase in stability of the p66shc adaptor protein: role in rac1-induced oxidative stress. Mol Biol Cell 2006;17:122–9
   PubMedGoogle Scholar
• Khanday FA, Santhanam L, Kasuno K, et al. SOS-mediated activation of Rac1 by p66shc. J Cell Biol 2006;172:817–22
   PubMedGoogle Scholar
• Trinei M, Giorgio M, Cicalese A, et al. A p53-p66Shc signalling pathway controls intracellular redox status, levels of oxidation damaged DNA and oxidative stress-induced apoptosis. Oncogene 2002;21:3872–8
   PubMed Web of Science ®Google Scholar
• Sulciner DJ, Irani K, Yu ZX, et al. Rac1 regulates a cytokine-stimulated, redox-dependent pathway necessary for NF-kappa B activation. Mol Cell Biol 1996;16:7115–21
   PubMedGoogle Scholar
• Sundaresan M, Yu ZX, Ferrans VJ, et al. Regulation of reactive-oxygen species generation in fibroblasts by Rac1. Biochem J 1996;318:379–82
   PubMed Web of Science ®Google Scholar
• Pandolfi S, Bonafe M, Di Tella L, et al. p66Shc is highly expressed in fibroblasts from centenarians. Mech Ageing Dev 2005;126:839–44
   Google Scholar
• Xie Y, Hung MC. P66shc isoform is down regulated and not required for HER-2/neu signaling pathway in human breast cancer cell lines with HER-2/neu overexpression. Biochem Biophys Res Commun 1996;221:140–5
   PubMed Web of Science ®Google Scholar
• Jackson JG, Yoneda T, Clark GM, Yee D. Elevated levels of p66shc are found in breast cancer cell lines and primary tumors with high metastatic potential. Clin Cancer Res 2000; 6:1135–9
   PubMed Web of Science ®Google Scholar
• Davol PA, Bagdasaryan R, Elfenbein GJ, et al. Shc proteins are strong, independent prognostic markers for both node-negative and node-positive primary breast cancer. Cancer Res 2003;63:6772–83
   PubMed Web of Science ®Google Scholar
• Lee MS, Igawa T, Chen SJ, et al. p66Shc Protein is up-regulated by steroid hormone-sensitive cancer cells and in primary prostate carcinomas. Int J Cancer 2004;108:672–8
   PubMed Web of Science ®Google Scholar
• Alam S, Rajendran M, Ouyang M, et al. A novel role of Shc adaptor proteins in steroid hormone-regulated cancers. Endocr Relat Cancer 2009;16:1–16
   Google Scholar
• Veeramani S, Igawa T, Yaun T, et al. Expression of p66shc protein correlates with proliferation of human prostate cancer cells. Oncogene 2005;24:7203–12
   PubMed Web of Science ®Google Scholar
• Grossman SR, Lyle S, Reshide MB, et al. P66shc tumor levels show a strong prognostic correlation with disease outcome in stage IIA colon cancer. Clin Cancer Res 2007;13:5798–804
   PubMed Web of Science ®Google Scholar
• Oshikawa J, Kim SJ, Furuta E, et al. Novel role of p66shc in ROS-dependent VEGF signaling and angiogenesis in endothelial cells. Am J Physiol Heart Circ Physiol 2012;302:724–32
   PubMed Web of Science ®Google Scholar
• Bashir M, Kirmani D, Bhat HF, et al. P66shc and its associate targets are upregulated in esophageal cancers. Cell Comm Signal 2010;1:8–13
   Google Scholar
• Fabbrocini G, Kisslinger A, Iannelli P, et al. Resveratrol regulates p66Shc activation in HaCaT cells. Exp Dermatol 2010;10:895–903
   Google Scholar
• Wang YN, Wu W, Chen HC, Fang H. Genistein protects against UVB-induced senescence-like characteristics in human dermal fibroblast by p66Shc down-regulation. J Dermatol Sci 2010;58:19–27
   Google Scholar
• Giovannini C, Scazzocchio B, Matarrese P, et al. Apoptosis induced by oxidized lipids is associated with up-regulation of p66Shc in intestinal Caco-2 cells: protective effects of phenolic compounds. J Nutr Biochem 2008;2:118–28
   Google Scholar
• Juan MC, Alicia P, Oriana B, et al. Vitamin C is a kinase inhibitor: dehydroascorbic acid inhibits IκBα kinase β. Mol Cell Biol 2004;15:6645–52
   Google Scholar
• Flohe L, Brigelius-Flohe R, Saliou C, et al. Redox regulation of NF-kB activation. Free Radic Biol Med 1997;22:1115–26
   PubMed Web of Science ®Google Scholar
• Mercurio F, Manning AM. NF-B as a primary regulator of the stress response. Oncogene 1999;18:6163–71
   PubMed Web of Science ®Google Scholar
• Bowie AG, O’Neill LA. Vitamin C inhibits NF-B activation by TNF via the activation of mitogen-activated protein kinase. J Immunol 2000;165:7180–8
   PubMed Web of Science ®Google Scholar
• Fiorani M, De Sanctis R, Scarlatti F, et al. Dehydroascorbic acid irreversibly inhibits hexokinase activity. Mol Cell Biochem 2000;20:145–53
   Google Scholar
• Witenberg B, Kalir HH, Raviv Z, et al. Inhibition by ascorbic acid of apoptosis induced by oxidative stress in HL-60 myeloid leukemia cells. Biochem Pharmacol 1999;57:823–32
   PubMed Web of Science ®Google Scholar
• Guaiquil VH, Vera JC, Golde DW. Mechanism of vitamin C inhibition of cell death induced by oxidative stress in glutathione-depleted HL 60 cells. J Biol Chem 2001;276:40955–61
   PubMed Web of Science ®Google Scholar
• Perez-Cruz I, Carcamo JM, Golde DW. Vitamin C inhibits FAS-induced apoptosis in monocytes and U937 cells. Blood 2003;102:336–43
   PubMed Web of Science ®Google Scholar
• Innocenti M, Tenca P, Frittoli E, et al. Mechanisms through which Sos-1 coordinates the activation of Ras and Rac. J Cell Biol 2002;156:125–36
   PubMed Web of Science ®Google Scholar
• Wybieralska E, Koza M, Sroka J, et al. Ascorbic acid inhibits the migration of Walker 256 carcinoma cells. Cell Mol Biol Lett 2008;13:103–11
   Google Scholar
• Zhang ZW, Patchett SE, Perrett, D, et al. The relation between gastric vitamin C concentrations, mucosal histology, and CagA seropositivity in the human stomach. Gut 1998;43:322–6
   PubMedGoogle Scholar
• Waring AJ, Drake IM, Schorah CJ, et al. Ascorbic acid and total vitamin C concentrations in plasma, gastric juice, and gastrointestinal mucosa: effects of gastritis and oral supplementation. Gut 1996;38:171–6
   PubMed Web of Science ®Google Scholar
• Schorah CJ. The transport of vitamin C and effects of disease. Proc Nutr Soc 1992;51:189–98
   PubMed Web of Science ®Google Scholar
• Sobala GM, Schorah CJ, Sanderson M, et al. Ascorbic acid in the human stomach. Gastroenterology 1989;97:357–63
   PubMed Web of Science ®Google Scholar
• Haramato M, Tatemoto H, Muto N. Essential role of ascorbic acid in neural differentiation and development: high levels of ascoric acid 2-glucoside effectively enhances nerve growth factor-induced neurite formation and elongation in PC12 cells. J Health Sci 2008;54:43–9
   Google Scholar
• Griendling KK, Sorescu D, Ushio-Fukai M. NAD(P)H oxidase: role in cardiovascular biology and disease. Circ Res 2000;86:494–501
   PubMed Web of Science ®Google Scholar